Fibrotic disease and the TH1/TH2 paradigm
Open accessThe DOI matches its Crossref record; 137 of the 137 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Similarly, interferon-γ (IFNγ), produced by many immune cells including NK, NKT and T cells, has direct anti-fibrogenic activity on HSCs (70–72).”
From Hepatic Stellate Cell-Immune Interactions in NASH (2022) · cites this paper as [71]
Experimental — accuracy not yet measuredIn the citing paper
“Recent evidence indicates that myofibroblast-induced fibrosis can be over-activated, not only in the setting of signaling through TGF-β, but also in the setting of Th2-derived cytokines IL-4 and IL-13; Th1 cytokines, such as IFN-γ, attenuate excessive scar formation [100, 101].”
From Immunology of Wound Healing (2018) · cites this paper as [100]
In the citing paper
“Recent evidence indicates that myofibroblast-induced fibrosis can be over-activated, not only in the setting of signaling through TGF-β, but also in the setting of Th2-derived cytokines IL-4 and IL-13; Th1 cytokines, such as IFN-γ, attenuate excessive scar formation [100, 101].”
From Immunology of Wound Healing (2018) · cites this paper as [100]
In the citing paper
“Recent evidence indicates that myofibroblast-induced fibrosis can be over-activated, not only in the setting of signaling through TGF-β, but also in the setting of Th2-derived cytokines IL-4 and IL-13; Th1 cytokines, such as IFN-γ, attenuate excessive scar formation [100, 101].”
From Immunology of Wound Healing (2018) · cites this paper as [100]
In the citing paper
“Normally, myofibroblasts carefully coordinate the breakdown of granulation tissue and replacement with long-lasting type I collagen [100].”
From Immunology of Wound Healing (2018) · cites this paper as [100]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Interleukin-10 and the Interleukin-10 Receptor
Moore, K. W., de Waal Malefyt, R., Coffman, R. L., & O'Garra, A. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.683 · Cited by 6,737 · cited 1×
“However, it is now described as a general immunosuppressive cytokine that downregulates chronic inflammatory responses through many mechanism”
BackgroundAlternative activation of macrophages
Gordon, S. (2003) · Nature Reviews Immunology · doi:10.1038/nri978 · Cited by 6,189
(1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-92-3-460_4 · Cited by 4,529
Functional diversity of helper T lymphocytes
Abbas, A. K., Murphy, K. M., & Sher, A. (1996) · Nature · doi:10.1038/383787a0 · Cited by 4,450
Interleukin-13: Central Mediator of Allergic Asthma
Wills-Karp, M., Luyimbazi, J., Xu, X., Schofield, B., Neben, T. Y., Karp, C. L., & Donaldson, D. D. (1998) · Science · doi:10.1126/science.282.5397.2258 · Cited by 2,617
Munger, J. S., Huang, X., Kawakatsu, H., Griffiths, M. J. D., Dalton, S. L., Wu, J., Pittet, J.-F., Kaminski, N., Garat, C., Matthay, M. A., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80545-0 · Cited by 2,076
Kulkarni, A. B., Huh, C. G., Becker, D., Geiser, A., Lyght, M., Flanders, K. C., Roberts, A. B., Sporn, M. B., Ward, J. M., & Karlsson, S. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.2.770 · Cited by 1,967
REGULATION OF IMMUNE RESPONSES BY TGF-β
Letterio, J. J., & Roberts, A. B. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.137 · Cited by 1,890
Requirement for IL-13 Independently of IL-4 in Experimental Asthma
Grünig, G., Warnock, M., Wakil, A. E., Venkayya, R., Brombacher, F., Rennick, D. M., Sheppard, D., Mohrs, M., Donaldson, D. D., Locksley, R. M., et al. (1998) · Science · doi:10.1126/science.282.5397.2261 · Cited by 1,849
Zhu, Z., Homer, R. J., Wang, Z., Chen, Q., Geba, G. P., Wang, J., Zhang, Y., & Elias, J. A. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5909 · Cited by 1,719
Cited by
Items 801–900 of 1,000
A primer on current progress in cardiac fibrosis
Al‐Hattab, D. S., & Czubryt, M. P. (2017) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2016-0687 · Cited by 31
Interferon-γ Treatment of Human Laryngotracheal Stenosis–Derived Fibroblasts
Motz, K., Samad, I., Yin, L. X., Murphy, M. K., Duvvuri, M., Ding, D., & Hillel, A. T. (2017) · JAMA Otolaryngology–Head & Neck Surgery · doi:10.1001/jamaoto.2017.0977 · Cited by 29
Menon, R. G., Raghavan, P., & Regatte, R. R. (2019) · Scientific Reports · doi:10.1038/s41598-019-50715-x · Cited by 30
Fang, J., Liu, R., Chen, S., Liu, Q., Cai, H., Lin, Y., Chen, Z., & Chen, Z. (2020) · Acta Biomaterialia · doi:10.1016/j.actbio.2020.03.038 · Cited by 29
Thy-1 (CD90), Integrins and Syndecan 4 are Key Regulators of Skin Wound Healing
González, L. P., Leyton, L., & Valdivia, A. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.810474 · Cited by 29
“Interferon γ secreted by Th1 cells can attenuate tissue fibrosis by downregulating collagen synthesis and decreasing fibroblast proliferation (Harrop et al., 1995; Wynn, 2004).”
BackgroundGagnon, J., Pi, L., Ryals, M. M., Wan, Q., Hu, W., Ouyang, Z., Zhang, B., & Li, K. (2022) · Life · doi:10.3390/life12060850 · Cited by 37
Nangia‐Makker, P., Hogan, V. A., Balan, V., & Raz, A. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.102622 · Cited by 30
“2) and is responsible for nearly 45% of all deaths (6).”
BackgroundBiodistribution, Dosimetry, and Pharmacokinetics of68Ga-CBP8: A Type I Collagen–Targeted PET Probe
Izquierdo‐Garcia, D., Désogère, P. A., Fur, M. L., Shuvaev, S., Zhou, I. Y., Ramsay, I. A., Lanuti, M. D., Catalano, O. A., Catana, C., Caravan, P. D., et al. (2022) · Journal of Nuclear Medicine · doi:10.2967/jnumed.122.264530 · Cited by 29
“Fibrotic diseases, such as cirrhosis, pulmonary fibrosis, and systemic sclerosis, or diseases with a fibroproliferative component, such as atherosclerosis, account for nearly half of all human deaths in the United States (1).”
BackgroundDewals, B. G., Hoving, J. C., Horsnell, W. G. C., & Brombacher, F. (2010) · European Journal of Immunology · doi:10.1002/eji.200940075 · Cited by 29
Investigational approaches to therapies for idiopathic pulmonary fibrosis
Gomer, R. H., & Lupher, M. L. (2010) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2010.484018 · Cited by 29
Dewals, B. G., Hoving, J. C., Leeto, M., Marillier, R. G., Govender, U., Cutler, A. J., Horsnell, W. G. C., & Brombacher, F. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.090137 · Cited by 38
Inhibition of Nuclear Factor-κB in T Cells Suppresses Lung Fibrosis
Fujimoto, H., D’Alessandro‐Gabazza, C. N., Palanki, M. S. S., Erdman, P. E., Takagi, T., Gabazza, E. C., Bruno, N. E., Yano, Y., Hayashi, T., Tamaki, S., et al. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200609-1288oc · Cited by 29
HCV–HIV Coinfection: Simple Messages from a Complex Disease
Klenerman, P., & Kim, A. Y. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040240 · Cited by 33
Immuno-modulatory Effect of IFN-gamma in AMD and its Role as a Possible Target for Therapy
Jiang, K., & Cao, S. (2011) · Journal of Clinical & Experimental Ophthalmology · doi:10.4172/2155-9570-s2-007 · Cited by 34
Gordon, S., & Plüddemann, A. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-31696-5.00010-3 · Cited by 29
Vidović, T., & Ewald, C. Y. (2022) · Frontiers in Aging · doi:10.3389/fragi.2022.935220 · Cited by 33
“Since tissue fibrosis is the leading cause of morbidity and mortality and more than 45% of deaths in the United States can be attributed to fibrotic disorders (Wynn, 2004), one of the reasons why mTOR inhibition increases lifespan may be due to preventing fibrotic disorders in tissues.”
BackgroundTANGO1 inhibitors reduce collagen secretion and limit tissue scarring
Raote, I., Rosendahl, A.-H., Häkkinen, H.-M., Vibe, C. B., Küçükaylak, I., Sawant, M., Keufgens, L., Frommelt, P., Halwas, K., Broadbent, K., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-47004-1 · Cited by 33
Lee, S. J., Park, J., Lee, J., Jeong, Y., Song, J. A., Lee, K., & Kim, D. (2016) · Journal of Toxicologic Pathology · doi:10.1293/tox.2015-0067 · Cited by 28
Cho, S., Roh, K., Park, J., Park, Y. S., Lee, M., Cho, S., Kil, E., Cho, M.-J., Oh, J. S., Byun, H.-S., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-00085-z · Cited by 28
Interleukin-36 Cytokine/Receptor Signaling: A New Target for Tissue Fibrosis
Melton, E. M., & Qiu, H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186458 · Cited by 30
“Several studies, for example, found that T helper 2 cells (Th2 T) cells produce IL-4, IL-13, and IL-5, which act on macrophages to induce the production of pro-fibrotic cytokines and growth factors (TGF-β and PDGF) that lead to fibrosis [1,71,72].”
BackgroundResultTherapeutic potential of Angelica sinensis in addressing organ fibrosis: A comprehensive review
Zhi, X., Ren, C., Li, Q., Xi, H., Li, D., Chen, Q., Lv, X., Gao, X., Wu, X. S., Wang, C., et al. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116429 · Cited by 32
The Role of Chemokines in Hepatitis C Virus-Mediated Liver Disease
Braß, A., & Brenndörfer, E. D. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15034747 · Cited by 33
Zhang, Y., Liu, P., Gao, X., Qian, W., & Xu, K. (2010) · Digestive Diseases and Sciences · doi:10.1007/s10620-009-1119-3 · Cited by 28
“Several cytokines regulate the inflammatory and remodeling process, including transforming growth factor (TGF)b, which appears to be a key mediator in liver fibrogenesis [6, 7].”
BackgroundNaCl Potentiates Human Fibrocyte Differentiation
Cox, N., Pilling, D., & Gomer, R. H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045674 · Cited by 32
Interleukin-1 receptor antagonist modulates inflammation and scarring after ligament injury
Chamberlain, C. S., Leiferman, E. M., Frisch, K. E., Duenwald-Kuehl, S. E., Brickson, S. L., Murphy, W. L., Baer, G. S., & Vanderby, R. (2014) · Connective Tissue Research · doi:10.3109/03008207.2014.906408 · Cited by 29
Pirfenidone treatment of idiopathic pulmonary fibrosis
Gomer, R. H., Gan, & Herzog, E. L. (2011) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s12209 · Cited by 33
Clinicopathological analysis of salivary gland tissue from patients with IgG4-related disease
Takano, K., Nomura, K., Abe, A., Kamekura, R., Yamamoto, M., Ichimiya, S., Takahashi, H., & Himi, T. (2016) · Acta Oto-Laryngologica · doi:10.3109/00016489.2016.1154605 · Cited by 28
Molecular and Cellular Biology of Wound Healing and Skin Regeneration
Sanon, S., Hart, D. A., & Tredget, E. E. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-801654-1.00002-4 · Cited by 33
Radiotherapy-Induced Skin Reactions Induce Fibrosis Mediated by TGF-β1 Cytokine
de Andrade, C. B. V., Ramos, I. P., de Moraes, A. C. N., Nascimento, A. L. R., Salata, C., Goldenberg, R. C. D. S., de Carvalho, J. J., & de Almeida, C. E. V. (2017) · Dose-Response · doi:10.1177/1559325817705019 · Cited by 33
Proximal interleukin‐10 gene polymorphisms in Italian patients with systemic sclerosis
Beretta, L., Cappiello, F., Barili, M., & Scorza, R. (2007) · Tissue Antigens · doi:10.1111/j.1399-0039.2007.00811.x · Cited by 28
Exosomal miRNAs in autoimmune skin diseases
Zhang, R., Wei, Y., Wang, T., Nie, X., Shi, Z., Deng, Y., & Li, D. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1307455 · Cited by 28
“…transplantation could improve bone loss in systemic sclerosis mice by modulating the differentiation of recipient bone marrow-MSCs probably attributed to miR-151-5p derived from MSC-derived exosomes by targeting IL-4Ra, consistent with a previous study identifying IL-4 as a suspicious pathway (60).”
ResultCytological changes in radiation-induced lung injury
Wang, Y., Zhang, J., & Shao, C. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.123188 · Cited by 31
Loganath, K., Craig, N. J., Barton, A. K., Joshi, S. S., Anagnostopoulos, C., Erba, P. A., Glaudemans, A. W. J. M., Saraste, A., Bucerius, J. A., Lubberink, M., et al. (2024) · Journal of Nuclear Cardiology · doi:10.1016/j.nuclcard.2024.102106 · Cited by 29
Expression of galectin-3 as a testis inflammatory marker in vasectomised mice.
Kashani, H. H., Moshkdanian, G., Atlasi, M. A., Taherian, A. A., Naderian, H., & Nikzad, H. (2013) · Europe PMC (PubMed Central) · Cited by 27
TH-1 and TH-2 Cytokines in Stable Chronic Alcoholics
González‐Reimers, E., Santolaria-Fernández, F., García, M., González-Pérez, J. M., de la Vega-Prieto, M. J., Medina-Vega, L., Martín-González, C., & Durán-Castellón, M. C. (2012) · Alcohol and Alcoholism · doi:10.1093/alcalc/ags041 · Cited by 30
Candidate rejuvenating factor GDF11 and tissue fibrosis: friend or foe?
Frohlich, J., & Vinciguerra, M. (2020) · GeroScience · doi:10.1007/s11357-020-00279-w · Cited by 28
Naiyila, X., Li, J., Huang, Y., Chen, B., Zhu, M., Li, J., Chen, Z., Yang, L., Ai, J., Wei, Q., et al. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12051821 · Cited by 36
“(Figure 1) This complex pro‐inflammatory microenvironment is closely related to the excessive proliferation of BPH stroma, similar to the myofibroblast‐based reactive matrix and extracellular matrix remodelling observed during wound repair in most inflammation‐related fibrosis diseases [55].”
BackgroundGrape seed pro‐anthocyanidins ameliorates radiation‐induced lung injury
Huang, Y., Liu, W., Liu, H., Yang, Y., Cui, J., Zhang, P., Zhao, H., He, F., Cheng, Y., Jin, N., et al. (2014) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12276 · Cited by 29
Neutralizing Th2 Inflammation in Neonatal Islets Prevents β-Cell Failure in Adult IUGR Rats
Santos, L. J. J., Li, C., Doulias, P., Ischiropoulos, H., Worthen, G. S., & Simmons, R. A. (2014) · Diabetes · doi:10.2337/db13-1226 · Cited by 29
Macrophages: The Bad, the Ugly, and the Good in the Inflammatory Response to Biomaterials
Scatena, M., Eaton, K. V., Jackson, M. F., Lund, S. A., & Giachelli, C. M. (2016) · Springer eBooks · doi:10.1007/978-3-319-45433-7_3 · Cited by 34
Mechanism of fibrosis inhibition in laser induced choroidal neovascularization by doxycycline
Peng, X., Hu, X., Tang, M., Zhan, Z., Yu, Y., Sun, L., Luo, X., Zhang, A., & Ding, X. (2018) · Experimental Eye Research · doi:10.1016/j.exer.2018.06.030 · Cited by 28
“STAT6 signaling May play important role in fibrosis inhibition of doxycycline STAT6 signaling driven by IL-13 was previously reported as one of the probable pathways to regulate polarization toward the M2 phenotype (Sica and Mantovani, 2012; Wynn, 2004).”
BackgroundComplement Activation in Progression of Chronic Kidney Disease
Chen, S., & Chen, M. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-8871-2_20 · Cited by 30
Fibroblast abnormalities in the pathogenesis of systemic sclerosis
Usategui, A., Rey, M. J. D., & Pablos, J. L. (2011) · Expert Review of Clinical Immunology · doi:10.1586/eci.11.39 · Cited by 28
Molecular and Cellular Basis of Hypertrophic Scarring
Kwan, P. O., Desmoulière, A., & Tredget, E. E. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-47661-4.00045-9 · Cited by 32
Liu, J., Ding, M., Bai, J., Luo, R., Liu, R., Qu, J., & Li, X. (2023) · iMeta · doi:10.1002/imt2.76 · Cited by 25
Li, J., Chen, G., Ye, P., Wang, S., 张凯伦, Chen, W., Stepkowski, S. M., Li, J., Zhong, S., & Xia, J. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002143 · Cited by 27
“In contrast, an AAM subset of macrophages has a well-established role in tissue homeostasis and repair with its potent anti-inflammatory properties (47, 48).”
BackgroundMolecular Mechanisms to Target Cellular Senescence in Hepatocellular Carcinoma
Mittermeier, C., Konopa, A., & Muehlich, S. (2020) · Cells · doi:10.3390/cells9122540 · Cited by 31
Widiapradja, A., Kasparian, A. O., McCaffrey, S. L., Kolb, L. L., Imig, J. D., Lacey, J. L., Meléndez, G. C., & Levick, S. P. (2021) · Cells · doi:10.3390/cells10102659 · Cited by 27
Emerging Anti-Inflammatory Pharmacotherapy and Cell-Based Therapy for Lymphedema
Ogino, R., Yokooji, T., Hayashida, M., Suda, S., Yamakawa, S., & Hayashida, K. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23147614 · Cited by 29
Strategic outline of interventions targeting extracellular matrix for promoting healthy longevity
Park, J. Y. C., King, A., Björk, V., English, B. W., Fedintsev, A., & Ewald, C. Y. (2023) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00060.2023 · Cited by 33
Alveolar Macrophages Play a Key Role in Cockroach-Induced Allergic Inflammation via TNF-α Pathway
Kim, J., Sohn, J.-H., Choi, J., Lee, J., Hong, C.-S., Lee, J.-S., & Park, J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047971 · Cited by 26
Interleukin-13 is involved in the formation of liver fibrosis in Clonorchis sinensis-infected mice
Xu, Y., Liang, P., Bian, M., Chen, W., Wang, X., Lin, J., Shang, M., Qu, H., Wu, Z., Huang, Y., et al. (2016) · Parasitology Research · doi:10.1007/s00436-016-5012-7 · Cited by 27
“CD4 T cells, especially T helper 2 (Th2) cells, play an important role in the formation of fibrosis (Wynn 2004; Wynn 2008).”
BackgroundFarris, A. B., Ellis, C. L., Rogers, T. E., Lawson, D., Cohen, C., & Rosen, S. (2016) · PLoS ONE · doi:10.1371/journal.pone.0161019 · Cited by 26
Al‐Fayoumi, S., Hashiguchi, T., Shirakata, Y., Mascarenhas, J. O., & Singer, J. W. (2018) · Journal of Experimental Pharmacology · doi:10.2147/jep.s150729 · Cited by 27
Pathogenesis of liver damage in HCV-HIV patients.
Bruno, R., Sacchi, P., Puoti, M., Maiocchi, L., Patruno, S. F. A., Cima, S., & Filice, G. (2008) · PubMed · Cited by 30
Role of cellular immunity in the pathogenesis of autoimmune skin diseases.
Alaibac, M., Berti, E., Chizzolini, C., Fineschi, S., Marzano, A. V., Pigozzi, B., Riboldi, E., Sozzani, S., & Kuhn, A. (2006) · PubMed · Cited by 26
Scarring and Skin Fibrosis Reversal with Regenerative Surgery and Stem Cell Therapy
Almadori, A., & Butler, P. E. M. (2024) · Cells · doi:10.3390/cells13050443 · Cited by 29
“…to find a cure for fibrosis (about 3000 clinical trials on fibrosis and scarring are currently listed on clinicaltrials.gov), clinical trials on fibrosis and scarring are currently listed on clinicaltrials.gov), an effective cure is still lacking [17]. an effective cure is still lacking [17].”
BackgroundAdvance in pathogenesis of sarcoidosis: Triggers and progression
Chen, C., Luo, N., Dai, F., Zhou, W., Wu, X., & Zhang, J. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e27612 · Cited by 42
van der Velden, J. L. J., Hoffman, S. M., Alcorn, J. F., Tully, J. E., Chapman, D. G., Lahue, K. G., Guala, A. S., Lundblad, L. K. A., Aliyeva, M., Daphtary, N., et al. (2014) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00153.2013 · Cited by 29
The evolving pharmacotherapy of pulmonary fibrosis
Lota, H., & Wells, A. U. (2012) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2013.758250 · Cited by 25
Recent Advances in Magnetic Resonance Imaging Assessment of Renal Fibrosis
Li, J., An, C., Kang, L., Mitch, W. E., & Wang, Y. (2017) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2017.03.005 · Cited by 25
Cardellini, M., Rizza, S., Casagrande, V., Cardolini, I., Ballanti, M., Davato, F., Porzio, O., Canale, M. P., Legramante, J. M., Mavilio, M., et al. (2018) · Acta Diabetologica · doi:10.1007/s00592-018-1230-z · Cited by 25
X-rays induced IL-8 production in lung cancer cells via p38/MAPK and NF-κB pathway
Song, Y., Chai, Q., Wang, N.-L., Yang, F., Wang, G., & Hu, J. (2019) · International Journal of Radiation Biology · doi:10.1080/09553002.2020.1683643 · Cited by 25
Song, M., Kim, D. I., & Lee, K. (2020) · Molecules · doi:10.3390/molecules25204684 · Cited by 27
A critical role of AREG for bleomycin-induced skin fibrosis
Zhang, M. Y., Fang, S., Gao, H., Zhang, X., Gu, D., Liu, Y., Wan, J., & Xie, J. (2021) · Cell & Bioscience · doi:10.1186/s13578-021-00553-0 · Cited by 28
The perplexing role of RAGE in pulmonary fibrosis: causality or casualty?
Perkins, T. N., & Oury, T. D. (2021) · Therapeutic Advances in Respiratory Disease · doi:10.1177/17534666211016071 · Cited by 26
Frantz, C., Cauvet, A., Durand, A., Gonzalez, V., Pierre, R., Cruzeiro, M. D., Bailly, K., Andrieu, M., Orvain, C., Avouac, J., et al. (2022) · Arthritis & Rheumatology · doi:10.1002/art.42111 · Cited by 27
Pereira, S., Orlandi, E. M., Deneuve, S., Barcellini, A., Chalaszczyk, A., Behm‐Ansmant, I., Hettal, L., Rancati, T., Vogin, G., & Thariat, J. (2022) · Cancers · doi:10.3390/cancers14246252 · Cited by 29
Famulski, K. S., Kayser, D., Einecke, G., Allanach, K., Badr, D., Venner, J. M., Sis, B., & Halloran, P. F. (2010) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2009.02983.x · Cited by 25
Chronic Graft-versus-Host Disease: How Can We Release Prometheus?
Teshima, T., Wynn, T. A., Soiffer, R. J., Matsuoka, K., & Martin, P. J. (2007) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2007.10.023 · Cited by 25
Self-citationMarcos, M., Pastor, I., González‐Sarmiento, R., & Laso, F. J. (2009) · Cytokine · doi:10.1016/j.cyto.2008.11.003 · Cited by 25
mPGES-1 null mice are resistant to bleomycin-induced skin fibrosis
McCann, M. R., Monemdjou, R., Ghassemi-Kakroodi, P., Fahmi, H., Pérez, G., Liu, S., Shiwen, X., Parapuram, S. K., Kojima, F., Denton, C. P., et al. (2011) · Arthritis Research & Therapy · doi:10.1186/ar3226 · Cited by 27
Advances in understanding the immunopathology of sarcoidosis and implications on therapy
Cinetto, F., & Agostini, C. (2016) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2016.1181541 · Cited by 26
Nieuwenhuizen, N. E., Herbert, D. R., Lopata, A. L., & Brombacher, F. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.5.2758 · Cited by 25
“Alternatively activated macrophages are thought to be important in chronic allergic diseases through their role in fibrosis (21), but the role of alternatively activated macrophages in acute allergic diseases such as anaphylaxis is unknown.”
BackgroundWang, J., Jiao, H., Stewart, T. L., Shankowsky, H. A., Scott, P. G., & Tredget, E. E. (2008) · Journal of Investigative Dermatology · doi:10.1038/jid.2008.164 · Cited by 25
A novel mechanoeffector role of fibroblast S100A4 in myofibroblast transdifferentiation and fibrosis
Southern, B. D., Li, H., Mao, H., Crish, J. F., Grove, L. M., Scheraga, R. G., Mansoor, S., Reinhardt, A., Abraham, S., Deshpande, G. M., et al. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.105530 · Cited by 27
“Fibrotic disorders account for approximately 45% of deaths in the United States (1).”
BackgroundWhite, M. J. V., Galvis-Carvajal, E., & Gomer, R. H. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1401777 · Cited by 24
Retnla Overexpression Attenuates Allergic Inflammation of the Airway
Lee, M.-R., Shim, D., Yoon, J., Jang, H. S., Oh, S.-W., Suh, S. H., Choi, J., & Oh, G. T. (2014) · PLoS ONE · doi:10.1371/journal.pone.0112666 · Cited by 24
Zhao, J., Zang, J., Lin, Y., Wang, Y., Li, D., & Meng, X. (2018) · Journal of Functional Foods · doi:10.1016/j.jff.2018.12.030 · Cited by 26
The immunopathogenesis of tuberculous pericarditis
Howlett, P. J., Bruyn, E. D., Morrison, H., Godsent, I. C., Wilkinson, K. A., Ntsekhe, M., & Wilkinson, R. J. (2020) · Microbes and Infection · doi:10.1016/j.micinf.2020.02.001 · Cited by 27
Aokage, T., Seya, M., Hirayama, T., Nojima, T., Iketani, M., Aoyama-Ishikawa, M., Terasaki, Y., Taniguchi, A., Miyahara, N., Nakao, A., et al. (2021) · BMC Pulmonary Medicine · doi:10.1186/s12890-021-01712-2 · Cited by 25
Gouardères, S., Ober, C., Doumard, L., Dandurand, J., Vicendo, P., Fourquaux, I., Golberg, A., Samouillan, V., & Gibot, L. (2021) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2021.09.025 · Cited by 28
Salvia miltiorrhiza in thorax and abdomainal organ fibrosis: A review of its pharmacology
Zhao, Y., Qi, J., Ping, D., Sun, X., Tao, Y., Liu, C., & Peng, Y. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.999604 · Cited by 34
“Organ fibrosis was a common endpoint of diverse chronic diseases with progressive tissue scarring and organ dysfunction that eventually led to organ failure and significant mortality world-wide (Wynn, 2004).”
BackgroundChen, H., Xia, Z., Qing, B., Wang, W., Gu, L., Chen, Y., Wang, J., & Yuan, Y. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1119139 · Cited by 32
Hasegawa, M., & Takehara, K. (2012) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2012.03.014 · Cited by 26
Selenium and exposure to fibrogenic mineral dust: A mini-review
Muzembo, B. A., Deguchi, Y., Ngatu, N. R., Eitoku, M., Hirota, R., & Suganuma, N. (2015) · Environment International · doi:10.1016/j.envint.2015.01.002 · Cited by 25
“…coupled with lymphocyte–monocyte crosstalk thatwithstands growth factor release, proteolytic enzyme production and fibrogenic cytokine release, leading to the accumulation of connective tissue and a remodeling of the lung architecture destroying the normal lung structure irreversibly (Wynn, 2004).”
BackgroundAtualização na etiopatogênese da esclerose sistêmica
Zimmermann, A. F., & Pizzichini, M. M. M. (2013) · Revista Brasileira de Reumatologia · doi:10.1016/j.rbr.2013.01.001 · Cited by 30
Zeisberg, M., Tampe, B., LeBleu, V. S., Tampe, D., Zeisberg, E. M., & Kalluri, R. (2014) · American Journal Of Pathology · doi:10.1016/j.ajpath.2014.06.014 · Cited by 24
Systemic Effector and Regulatory Immune Responses to Chlamydial Antigens in Trachomatous Trichiasis
Gall, A., Horowitz, A., Joof, H., Natividad, A., Tetteh, K., Riley, E., Bailey, R., Mabey, D., & Holland, M. J. (2010) · Front. Microbio. · doi:10.3389/fmicb.2011.00010 · Cited by 198
Propolis reduces Leishmania amazonensis-induced inflammation in the liver of BALB/c mice
da Silva, S. S., Mizokami, S. S., Fanti, J. R., Miranda-Sapla, M. M., Kawakami, N. Y., Humel, F., Araújo, E. J. D. A., Panis, C., Watanabe, M. A. E., Sforcin, J. M., et al. (2015) · Parasitology Research · doi:10.1007/s00436-015-4890-4 · Cited by 24
“However, the pathogenesis of fibrous tissue involves IL-13 associated with a cascade of events that involve an increase of TGF-β and TNF-α, regulating collagen synthesis and collagen catabolism (Wynn 2004; FichtnerFeigl et al. 2006).”
BackgroundCan Serum ST2 Levels Be Used as a Marker of Fibrosis in Chronic Hepatitis B Infection?
Öztaş, E., Kuzu, U. B., Zengın, N., Kalkan, İ. H., Saygılı, F., Yıldız, H., Çelik, H. T., Akdoğan, M., Kiliç, M. Y., Köksal, A. Ş., et al. (2015) · Medicine · doi:10.1097/md.0000000000001889 · Cited by 24
Gallardo, F. S., Córdova-Casanova, A., & Brandan, E. (2021) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-021-00610-w · Cited by 29
“They also express arginase I, which uses arginine, the same substrate of iNOS, to produce proline, which is required for collagen synthesis (Wynn 2004).”
BackgroundHuman T cells stimulate fibroblast-mediated degradation of extracellular matrix in vitro
Mikko, M., Fredriksson, K., Wahlström, J., Eriksson, P. O., Grünewald, J., & Sköld, C. M. (2007) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2007.03565.x · Cited by 27
Inhibition of type III TGF-β receptor aggravates lung fibrotic process
Ahn, J., Park, S., Yun, Y., & Song, J. (2010) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2010.01.006 · Cited by 24
Misson, P., Brombacher, F., Delos, M., Lison, D., & Huaux, F. (2006) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00503.2005 · Cited by 24
MMP-3 mediates copper oxide nanoparticle-induced pulmonary inflammation and fibrosis
Zhang, Y., Zhang, Z., Mo, Y., Zhang, Y., Yuan, J., & Zhang, Q. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02707-x · Cited by 23
Microvascular targets for anti-fibrotic therapeutics.
Pu, K.-M., Sava, P., & Gonzalez, A. L. (2013) · PubMed Central · Cited by 29
Intestinal Irradiation and Fibrosis in a Th1-Deficient Environment
Linard, C., Billiard, F., & Benderitter, M. (2012) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2011.11.027 · Cited by 25
Immunotherapy for pancreatic ductal adenocarcinoma: an overview of clinical trials.
Paniccia, A., Merkow, J. S., Edil, B. H., & Zhu, Y. (2015) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.1000-9604.2015.05.01 · Cited by 26
Immunoengineering approaches for cytokine therapy
Mansurov, A., Lauterbach, A. L., Budina, E., Alpar, A. T., Hubbell, J. A., & Ishihara, J. (2021) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00515.2020 · Cited by 25
Metadata
- Authors
- Wynn, T. A.
- Affiliations
- National Institutes of Health (US)
- Corresponding author
- Wynn, Thomas A.
- ORCID
- Wynn, Thomas A.
- Venue
- Nature Reviews Immunology
- Published
- 2004-08
- Volume
- 4
- Issue
- 8
- Pages
- 583-594
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- PMC
- PMC2702150
- OpenAlex
- W1983357763
- Cited by
- 1,765
- References
- 135
- Citations by year
- 2026: 46 · 2025: 76 · 2024: 93 · 2023: 104 · 2022: 126 · 2021: 96 · 2020: 99 · 2019: 83 · 2018: 91 · 2017: 95 · 2016: 87 · 2015: 91 · 2014: 94 · 2013: 82 · 2012: 75
- FWCI
- 8.75
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Immunology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases (Z01AI001019, Z01AI000829)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Health Sciences › Medicine › Rheumatology › Systemic Sclerosis and Related Diseases
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Keywords
- fibrosis, fibrogenesis, Th1/Th2 paradigm, T helper cells, idiopathic pulmonary fibrosis, liver fibrosis, systemic sclerosis, wound healing, fibroproliferative disorders
- MeSH terms
- Animals, Fibroblasts, Fibrosis, Humans, Macrophages, Transforming Growth Factor beta, Th1 Cells, Th2 Cells, Interleukin-13, Chemokines
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.